gene editing

Stem cell transplant eradicates HIV in second patient

https://pharmaphorum.com/news/stem-cell-transplant-eradicates-hiv-in-second-patient/

First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug

https://pharmaphorum.com/news/first-patient-dosed-in-trial-of-allergan-editas-crispr-blindness-drug/

4th Annual Genome Editing USA Congress

https://pharmaphorum.com/partner-content/4th-annual-genome-editing-usa-congress/

CRISPR trials yield encouraging data in blood disorders

https://pharmaphorum.com/news/crispr-trials-yield-encouraging-data-in-blood-disorders/

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

https://pharmaphorum.com/news/novo-nordisk-builds-in-haemophilia-with-bluebird-bio-gene-editing-deal/

Broad, MilliporeSigma issue call to make access to CRISPR freer

https://pharmaphorum.com/news/broad-milliporesigma-issue-call-to-make-access-to-crispr-freer/

FDA gives go-ahead for CRISPR-based sickle cell disease trial

https://pharmaphorum.com/news/fda-gives-go-ahead-for-crispr-based-sickle-cell-disease-trial/

The 10th Annual RNA Therapeutics Returns to London this Feb!

https://pharmaphorum.com/partner-content/the-10th-annual-rna-therapeutics-returns-to-london-this-feb/

Queen’s University Belfast and Santen to Present Opening Keynote this November

https://pharmaphorum.com/partner-content/queens-university-belfast-and-santen-to-present-opening-keynote-this-november/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search